See the factory by live video walkthrough
Book an on-site factory visit in GuangzhouWhen sourcing men’s deodorant or antiperspirant, the compliance boundary can shift your product from a simple cosmetic to an Over-the-Counter (OTC) drug—especially in regulated markets like the U.S. Understanding where that line falls helps…
When sourcing men’s deodorant or antiperspirant, the compliance boundary can shift your product from a simple cosmetic to an Over-the-Counter (OTC) drug—especially in regulated markets like the U.S. Understanding where that line falls helps brand owners avoid relabeling delays, costly re-testing, or customs rejections. The following guide breaks down core distinctions, evidence to request from your manufacturer, and a compliance checklist to keep your product launch on track.
In the men’s care category, product classification depends mainly on intended use and active ingredients:
In the EU and many Asia-Pacific markets, the line may remain within cosmetic definitions, but claims like “controls sweat for 24 hours” could still trigger functional or regulatory review. Always verify the applicable cosmetics regulation or monograph.
| Evidence Type | Why It Matters | Who Provides It |
|---|---|---|
| INCI list & full formula disclosure | Confirms presence/absence of OTC actives | Manufacturer |
| Stability & micro reports | Ensures formula is stable and safe across shelf life | Lab / QA |
| OTC monograph alignment doc | Required for any antiperspirant claim | Regulatory consultant / Manufacturer |
| Drug Facts label proof | Verifies correct OTC layout and compliant language | Regulatory / Labeling team |
| Product Information File (EU) | Mandatory for cosmetic-only products in EU | Manufacturer |
✓ Confirm if active ingredient matches FDA-approved monograph
✓ Obtain Certificate of Analysis (COA) for actives
✓ Review full formula for restricted substances
✓ Request batch record or Master Manufacturing Record (MMR)
✓ Audit Drug Facts label and claims
✓ Validate all raw material SDS and supplier COS reports
✓ Lock artwork with compliance approval before print
✓ Schedule pilot batch for stability and micro testing
✓ Archive all test certificates and regulatory filings
✓ Verify manufacturer’s FDA registration and facility number
✓ Ensure claims substantiation for odor/sweat reduction
✓ Document packaging compatibility testing results
Yes. Any product claiming to prevent or reduce perspiration falls under the FDA’s OTC monograph for antiperspirant drug products.
No. Any sweat-control claim requires monograph compliance and specific labeling, even if minimal actives are present.
Deodorants in the EU are treated as cosmetics; you need a Product Information File, safety assessment, and stability/micro testing.
Only if distinct claim sets and labeling are used. Regulatory classification is driven by claim, not just formula composition.
If aligned with an existing monograph and manufactured in a registered facility, the setup time mainly depends on documentation—4–8 weeks on average.
Request a Quote to discuss compliant men’s deodorant or antiperspirant development, including formula, label pack, and testing support for your market.